Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis

Abstract

Our findings demonstrate that affordable drug treatment costs are possible for novel cancer drugs, suggesting that new therapeutic options can be made available to patients and doctors worldwide. Assessing treatment cost estimations alongside cost-effectiveness evaluations is an important area of future research.